Post Coronavirus Disease 2019 (COVID-19) pulmonary fibrosis: a 12 months follow-up study
M. Daverio (Padova, Italy), E. Cocconcelli (Padova, Italy), N. Bernardinello (Padova, Italy), S. Petrarulo (Padova, Italy), M. Bovo (Padova, Italy), C. Dartora (Padova, Italy), E. De Zorzi (Padova, Italy), S. Tonin (Padova, Italy), A. Cattelan (Padova, Italy), C. Giraudo (Padova, Italy), M. Saetta (Padova, Italy), P. Spagnolo (Padova, Italy), E. Balestro (Padova, Italy)
Source: International Congress 2022 – COVID infections prognosis: risk factors and treatment
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Daverio (Padova, Italy), E. Cocconcelli (Padova, Italy), N. Bernardinello (Padova, Italy), S. Petrarulo (Padova, Italy), M. Bovo (Padova, Italy), C. Dartora (Padova, Italy), E. De Zorzi (Padova, Italy), S. Tonin (Padova, Italy), A. Cattelan (Padova, Italy), C. Giraudo (Padova, Italy), M. Saetta (Padova, Italy), P. Spagnolo (Padova, Italy), E. Balestro (Padova, Italy). Post Coronavirus Disease 2019 (COVID-19) pulmonary fibrosis: a 12 months follow-up study. 3372
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|